- Home
- TKNO vs ZVRA Comparison
TKNO vs ZVRA Comparison
Compare TKNO & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- ZVRA
- Stock Information
- Founded
- TKNO 1996
- ZVRA 2006
- Country
- TKNO United States
- ZVRA United States
- Employees
- TKNO N/A
- ZVRA N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TKNO Health Care
- ZVRA Health Care
- Exchange
- TKNO Nasdaq
- ZVRA Nasdaq
- Market Cap
- TKNO 356.4M
- ZVRA 400.8M
- IPO Year
- TKNO 2021
- ZVRA 2015
- Fundamental
- Price
- TKNO $6.96
- ZVRA $7.87
- Analyst Decision
- TKNO Buy
- ZVRA Strong Buy
- Analyst Count
- TKNO 1
- ZVRA 8
- Target Price
- TKNO $5.00
- ZVRA $22.29
- AVG Volume (30 Days)
- TKNO 431.4K
- ZVRA 453.2K
- Earning Date
- TKNO 05-08-2025
- ZVRA 05-13-2025
- Dividend Yield
- TKNO N/A
- ZVRA N/A
- EPS Growth
- TKNO N/A
- ZVRA N/A
- EPS
- TKNO N/A
- ZVRA N/A
- Revenue
- TKNO $38,250,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- TKNO $9.58
- ZVRA $267.44
- Revenue Next Year
- TKNO $15.97
- ZVRA $90.10
- P/E Ratio
- TKNO N/A
- ZVRA N/A
- Revenue Growth
- TKNO 3.79
- ZVRA N/A
- 52 Week Low
- TKNO $1.16
- ZVRA $4.20
- 52 Week High
- TKNO $10.37
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- TKNO 63.43
- ZVRA 58.11
- Support Level
- TKNO $5.70
- ZVRA $7.26
- Resistance Level
- TKNO $6.85
- ZVRA $8.10
- Average True Range (ATR)
- TKNO 0.50
- ZVRA 0.36
- MACD
- TKNO 0.03
- ZVRA 0.08
- Stochastic Oscillator
- TKNO 70.79
- ZVRA 80.34
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.